// September 21, 2023
Beyond TB medicines: How quality assurance is elevating health systems in Central Asia
In Central Asia and Eastern Europe, multidrug-resistant tuberculosis (MDR-TB) accounts for a sign
In Central Asia and Eastern Europe, multidrug-resistant tuberculosis (MDR-TB) accounts for a sign
The development of generic versions of innovator medicines is a global public health need.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
Hundreds of global public health experts converged in late May 2023 in Geneva, Switzerland for th